Contineum Therapeutics (NasdaqGS:CTNM) FY Conference Transcript
Contineum Therapeutics (NasdaqGS:CTNM) FY Conference September 08, 2025 08:30 AM ET Company ParticipantsCarmine Stengone - President, CEO & DirectorConference Call ParticipantsSean Laaman - Research Analyst - Biotechnology Small & MidcapNoneAll right, let's get to the live questions.Sean LaamanGood morning, everyone, and welcome to the Morgan Stanley Global Healthcare Conference. I'm Sean Lammon, Head of SMID-cap Biotech Equity Research here at the firm. For important disclosures, please see Morgan Stanley ...